Rheumatology, Vol 38, 448-452, Copyright © 1999 by British Society for Rheumatology
A Perdriger, P Guggenbuhl, G Chales, J Yaouanq, E Quelvennec, MN Bonnard, Y Pawlotsky and G Semana
OBJECTIVE: HLA DM is a non-classical major histocompatibility complex (MHC)
class II molecule that has been shown to facilitate peptide loading with
classical class II molecules. METHODS: In this study, we analysed the
polymorphism in exon 3 of HLA DMA and DMB genes by a polymerase chain
reaction-sequence-specific oligonucleotide probe method in 163 rheumatoid
arthritis (RA) patients and 146 ethnically matched controls. The HLA-DRB1
genotype was also analysed by a reverse- dot blot method. RESULTS: Our
results show in RA patients a significant increase in the HLA DMB*0101
allele frequency (83% vs 72.3% of the controls, P < 1.6 x 10(-3),
significance at P < 0.0125) and in the HLA DMB*0101-0101 homozygote
genotype frequency [70.8% vs 50% of the controls, P < 4.2 x 10(-4),
significance at P < 0.00625, odds ratio (OR) = 2.4, 95% confidence
interval (CI): 1.43-4]. The increase in DMB*0101 allele and homozygote
genotype frequencies was independent of a linkage disequilibrium between
DMB and DRB1 alleles. The analysis of non-random associations between the
HLA-DM and DRB1 alleles only revealed a significant association in controls
between DMB*0104 and DRB1*07 alleles (delta = 0.01, P < 7 x 10(-4),
significance at P < 9.6 x 10(-4)). On the other hand, the DMB*0101-0102
genotype frequency was increased in DRB1*0401-negative RA patients as
compared to controls (11% vs 2%, P < 0.011, significance at P <
0.015, OR = 6.2, 95% CI: 1.2- 30). CONCLUSION: Our data suggest that HLA-DM
alleles could play a role in the genetic susceptibility to RA.
ORIGINAL PAPERS
Positive association of the HLA DMB1*0101-0101 genotype with rheumatoid arthritis
Department of Rheumatology, Teaching Hospital, Rennes, France.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J Morel, F Roch-Bras, N Molinari, J Sany, J F Eliaou, and B Combe HLA-DMA*0103 and HLA-DMB*0104 alleles as novel prognostic factors in rheumatoid arthritis Ann Rheum Dis, December 1, 2004; 63(12): 1581 - 1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
M L Sanchez, K Katsumata, T Atsumi, F I Romero, M L Bertolaccini, A Funke, O Amengual, E Kondeatis, R W Vaughan, A Cox, et al. Association of HLA-DM polymorphism with the production of antiphospholipid antibodies Ann Rheum Dis, December 1, 2004; 63(12): 1645 - 1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Lich, J. A. Jayne, D. Zhou, J. F. Elliott, and J. S. Blum Editing of an Immunodominant Epitope of Glutamate Decarboxylase by HLA-DM J. Immunol., July 15, 2003; 171(2): 853 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Castro, E Acevedo, E Ciusani, J A Angulo, F A Wollheim, and M Sandberg-Wollheim Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis Ann Rheum Dis, August 1, 2001; 60(8): 791 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J Kilmartin, D. Wilson, J. Liversidge, A. D Dick, J. Bruce, R. W Acheson, S. J Urbaniak, and J. V Forrester Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients Br J Ophthalmol, March 1, 2001; 85(3): 281 - 286. [Abstract] [Full Text] |
||||


